Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia

European Journal of Pharmacology

Volumn 497, Issue 3, 2004, Pages 327-334

  Ohtake, Akiyoshi ^a   Sato, Shuichi ^a   Saitoh, Chikashi ^a   Yuyama, Hironori ^a   Sasamata, Masao ^a   Miyata, Keiji ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Arterial blood pressure; Intraurethral pressure; Tamsulosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL; PRAZOSIN; TAMSULOSIN; URAPIDIL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; DOG; DOSE RESPONSE; DRUG EFFECT; DYSURIA; FEMALE; HYPOGASTRIC NERVE; MALE; MEAN ARTERIAL PRESSURE; NERVE STIMULATION; NONHUMAN; PRESSURE; PRIORITY JOURNAL; SEX DIFFERENCE; URETHRA PRESSURE;

EID: 4444226268     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.066     Document Type: Article

References (39)

1. P. Abrams New words for old: lower urinary tract symptoms for prostatism Br. Med. J. 308 1994 929 930
2. 1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia) Br. J. Urol. 80 1997 587 596
3. 1A-agonistic properties of naftopidil, a novel antihypertensive drug Eur. J. Pharmacol. 205 1991 105 107
4. T.C. Chai, W.D. Belville, E.J. Mcguire, and L. Nyquist Specificity of the American Urological Association Voiding Symptom Index: comparison of unselected and selected samples of both sexes J. Urol. 150 1993 1710 1713
5. B. Djavan Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life Urology 62 3 Suppl 1 2003 6 14
6. T.R. Elliot The innervation of the bladder and urethra J. Physiol. 35 1907 367 445
7. 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy Eur. J. Pharmacol. 288 1995 201 207
8. C. Forray, J.A. Bard, J.M. Wetzel, G. Chiu, E. Shapiro, R. Tang, H. Lepor, P.R. Hartig, R.L. Weinshank, and T.A. Brancheck The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype Mol. Pharmacol. 45 1994 703 708
9. 1-adrenoceptor antagonist with uroselective properties J. Pharmacol. Exp. Ther. 300 2002 478 486
10. T. Hatanaka, S. Sato, A. Ohtake, M. Suzuki, and K. Miyata Effect of tamsulosin on phenylephrine-induced intraurethral pressure elevation in conscious dogs: the relationship between pharmacokinetics and pharmacodynamics J. Urol. 165 2001 211 212 (Suppl)
11. 1- adrenoceptors: consensus update Pharmacol. Rev. 47 1995 267 270
12. 2+ antagonistic effects J. Cardiovasc. Pharmacol. 17 1991 213 221
13. J. Imagawa, M. Akima, and K. Sakai Functional evaluation of sympathetically mediated responses in in vivo lower urinary tract of dogs J. Pharmacol. Methods 22 1989 103 111
14. H. Kakizaki, and T. Koyanagi Current view and status of the treatment of lower urinary tract symptoms and neurogenic lower urinary tract dysfunction BJU Int. 85 Suppl 2 2000 25 30
15. 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses Br. J. Urol. 80 1997 606 611
16. 1-adrenoceptor antagonist in the lower urinary tract Br. J. Pharmacol. 109 1993 1282 1289
17. A. Leonardi, J.P. Hieble, L. Guarneri, D.P. Naselsky, E. Poggesi, G. Sironi, A.C. Sulpizio, and R. Testa Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB216469): role of the alpha-1L adrenoceptor in tissue selectivity: Part I J. Pharmacol. Exp. Ther. 281 1997 1272 1283
18. 1C) adrenoceptor subtype Br. J. Pharmacol. 115 1995 781 786
19. 1-adrenoceptor subtypes Naunyn-Schmiedebergs Arch. Pharmakol. 352 1995 1 10
20. P. Narayan, and A. Tewari Overview of α-blocker therapy for benign prostatic hyperplasia Urology 51 Suppl 4A 1998 38 45
21. P. Narayan, C.P. Evans, and T. Moon Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia J. Urol. 170 2003 498 502
22. 1- adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue Br. J. Pharmacol. 119 1996 797 803
23. 1- adrenoceptor subtype mRNAs in human proximal urethra Br. J. Pharmacol. 123 1998 1289 1293
24. 1-adrenoceptors in rat tissues in relation to the plasma concentration Life Sci. 63 1998 2147 2155
25. K. Okamura, T. Usami, K. Nagahama, S. Maruyama, and E. Mizuta The relationships among filling, voiding subscores from international prostate symptom score and quality of life in Japanese elderly men and women Eur. Urol. 42 2002 498 505
26. D.T. Price, D.A. Schwinn, J.W. Lomasney, L.F. Allen, M.G. Caron, and R.J. Lefkowitz Identification, quantification, and localization of mRNA for three distinct alpha-1-adrenergic receptor subtypes in human prostate J. Urol. 150 1993 546 551
27. 1A receptors Br. J. Pharmacol. 102 1991 998 1002
28. 1-adrenergic receptors by vessel bed and age Circulation 100 1999 2336 2343
29. S. Sato, A. Ohtake, H. Matsushima, C. Saitoh, S. Usuda, and K. Miyata Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin J. Pharmacol. Exp. Ther. 296 2001 697 703
30. H.M. Scarpero, J. Fiske, X. Xue, and V.W. Nitti American urological association symptom index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life Urology 61 2003 1118 1122
31. E. Shapiro, and H. Lepor The relationship between histological and clinical response to alpha blockade in men with symptomatic BPH J. Urol. 145 1991 265A (Suppl)
32. E. Shapiro, and H. Lepor Pathophysiology of clinical benign prostatic hyperplasia Urol. Clin. North Am. 22 1995 285 290
33. M. Shibasaki, K. Sudoh, O. Inagaki, W. Uchida, and K. Honda Effect of optimal isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs J. Auton. Pharm. 12 1992 263 268
34. 1-adrenoceptors Jpn. J. Pharmacol. 79 1999 447 454
35. 1- adrenoceptor antagonist Yakugaku Zasshi 115 1995 773 789
36. K. Taguchi, M. Saitoh, S. Sato, M. Asano, and M.C. Michel Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes J. Pharmacol. Exp. Ther. 280 1997 1 5
37. 1- adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man Eur. J. Pharmacol. 249 1993 307 315
38. 1-adrenoceptor antagonist binding in human prostate and aorta Clin. Exp. Pharmacol. Physiol. 21 1994 405 411
39. 1-adrenoceptor antagonists J. Pharmacol. Exp. Ther. 300 2002 495 503